These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15333491)

  • 1. Combination therapy with fenofibrate and rosiglitazone paradoxically lowers serum HDL cholesterol.
    Normén L; Frohlich J; Montaner J; Harris M; Elliott T; Bondy G
    Diabetes Care; 2004 Sep; 27(9):2241-2. PubMed ID: 15333491
    [No Abstract]   [Full Text] [Related]  

  • 2. [HDL cholesterol reduction during rosiglitazone and fenofibrate treatment in a type 2 diabetes mellitus patient with dyslipidemia].
    Im M; Kim M; Lee JK; Chang YH; Lee DY; Hong SI; Lee YY; Hong YJ
    Korean J Lab Med; 2010 Feb; 30(1):17-9. PubMed ID: 20197717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on: Boden et al. (2007) Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: prevention of fluid retention: Diabetes 56:248-255.
    Stroup JS
    Diabetes; 2007 May; 56(5):e1; author reply e2. PubMed ID: 17470558
    [No Abstract]   [Full Text] [Related]  

  • 4. Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid Trial.
    Linz PE; Lovato LC; Byington RP; O'Connor PJ; Leiter LA; Weiss D; Force RW; Crouse JR; Ismail-Beigi F; Simmons DL; Papademetriou V; Ginsberg HN; Elam MB
    Diabetes Care; 2014; 37(3):686-93. PubMed ID: 24296848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of dual PPAR alpha/gamma stimulation with combination of rosiglitazone and fenofibrate on metabolic parameters in type 2 diabetic patients.
    Seber S; Ucak S; Basat O; Altuntas Y
    Diabetes Res Clin Pract; 2006 Jan; 71(1):52-8. PubMed ID: 16009445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical severe decrease in high-density lipoprotein cholesterol due to rosiglitazone-fenofibrate interaction.
    Schwing W; Hustak L; Taylor HC
    Endocr Pract; 2010; 16(3):382-8. PubMed ID: 20061291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of antilipemic therapy on patients with diabetes mellitus and obesity].
    Ungureanu D; Coman A; Maftei M; Popovici I; Artenie A; Artenie R
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):551-5. PubMed ID: 14756060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic improvement in insulin resistance with a combination of fenofibrate and rosiglitazone in obese type 2 diabetic mice.
    Choi WS; Lee JJ; Kim Y; Kim IS; Zhang WY; Myung CS
    Arch Pharm Res; 2011 Apr; 34(4):615-24. PubMed ID: 21544727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiazolidinediones and lowered HDL cholesterol.
    Savage RL; Kiuru A
    Diabetes Care; 2005 Sep; 28(9):2329-30. PubMed ID: 16123514
    [No Abstract]   [Full Text] [Related]  

  • 10. High incidence of reduced plasma HDL cholesterol in diabetic patients treated with rosiglitazone and fibrate.
    Keidar S; Guttmann H; Stam T; Fishman I; Shapira C
    Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1192-4. PubMed ID: 17636555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinopathy progression in type 2 diabetes.
    Baum SJ
    N Engl J Med; 2010 Nov; 363(22):2172; author reply 2173-4. PubMed ID: 21105808
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute myopathy in a type 2 diabetic patient on combination therapy with metformin, fenofibrate and rosiglitazone.
    Ledl M; Hohenecker J; Francesconi C; Roots I; Bauer MF; Roden M
    Diabetologia; 2005 Oct; 48(10):1996-8. PubMed ID: 16132947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical lowering of high-density lipoprotein cholesterol level in 2 patients receiving fenofibrate and a thiazolidinedione.
    Ebcioglu Z; Morgan J; Carey C; Capuzzi D
    Ann Intern Med; 2003 Nov; 139(9):W80. PubMed ID: 14597479
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone.
    Ronsein GE; Reyes-Soffer G; He Y; Oda M; Ginsberg H; Heinecke JW
    Mol Cell Proteomics; 2016 Mar; 15(3):1083-93. PubMed ID: 26667175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
    Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
    Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Are pioglitazone and fenofibrate effective for the prevention of cardiovascular disease in type 2 diabetes?].
    Ruiz J
    Rev Med Suisse; 2006 Jan; 2(48):116-8. PubMed ID: 16463795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination lipid therapy in type 2 diabetes.
    Perkins WJ
    N Engl J Med; 2010 Aug; 363(7):694; author reply 694-5. PubMed ID: 20842773
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination lipid therapy in type 2 diabetes.
    Sacks FM; Carey VJ; Fruchart JC
    N Engl J Med; 2010 Aug; 363(7):692-4; author reply 694-5. PubMed ID: 20842772
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe decrease in serum HDL-cholesterol during combination therapy of bezafibrate and pioglitazone.
    Senba H; Kawano M; Kawakami M
    J Atheroscler Thromb; 2006 Oct; 13(5):263-4. PubMed ID: 17146155
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia.
    Goldberg RB; Kendall DM; Deeg MA; Buse JB; Zagar AJ; Pinaire JA; Tan MH; Khan MA; Perez AT; Jacober SJ;
    Diabetes Care; 2005 Jul; 28(7):1547-54. PubMed ID: 15983299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.